National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 9491 [2016-03995]
Download as PDF
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
Dated: February 19, 2016.
Celia Wolfman,
Project Clearance Liaison, FIC, NIH.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2016–04050 Filed 2–24–16; 8:45 am]
BILLING CODE 4140–01–P
Government-Owned Inventions;
Availability for Licensing
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
ACTION:
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK4VPTVN1PROD with NOTICES
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: March 25, 2016.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Jay B. Sundstrom, Ph.D.,
Scientific Review Official, Scientific Review
Program, Division of Extramural Activities,
Room 3G11A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5045,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 19, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:07 Feb 24, 2016
Jkt 238001
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR part 404 to
achieve expeditious commercialization
of results of federally-funded research
and development.
FOR FURTHER INFORMATION CONTACT:
Licensing information may be obtained
by emailing the indicated licensing
contact at the National Heart, Lung, and
Blood, Office of Technology Transfer
and Development Office of Technology
Transfer, 31 Center Drive Room 4A29,
MSC2479, Bethesda, MD 20892–2479;
telephone: 301–402–5579. A signed
Confidential Disclosure Agreement may
be required to receive any unpublished
information.
SUPPLEMENTARY INFORMATION:
Technology description follows.
SUMMARY:
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
[FR Doc. 2016–03995 Filed 2–24–16; 8:45 am]
National Institutes of Health,
HHS.
Software for Fully Automating
Myocardial Perfusion Quantification
Description of Technology
Software is has been developed and
available for licensing that fully
automates image processing for the
quantification of myocardial blood flow
(MBF) pixel maps from first-pass
contrast-enhanced cardiac magnetic
resonance (CMR) perfusion images. The
system removes the need for laborious
manual quantitative CMR perfusion
pixel map processing and can process
prospective and retrospective studies
acquired from various imaging
protocols. In full automation, arterial
input function (AIF) images are
processed for motion correction and
myocardial perfusion images are
corrected for intensity bias. The
corrected AIF images are processed for
left ventricle signal detection and the
corrected myocardial perfusion images
and processed for myocardial signal
detection. Both data sets are then
corrected for nonlinear signaling,
synchronized, and pixel-wise
deconvolution processed. The resulting
pixel map shows accurate myocardial
blood flow.
Potential Commercial Applications:
• MRI Imaging of the myocardium
• Blood Perfusion Imaging
Development Stage:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
9491
• In vivo data
• Software system
• Source code.
Inventors: Li-Yueh Hsu, Matthew
Jacobs, Mitchel Benovoy, Andrew Arai
(NHLBI)
Intellectual Property: HHS Reference
No. E–097–2016/0—Software Materials.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@mail.nih.gov.
Dated: January 15, 2016.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2016–03990 Filed 2–24–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Impact of Clinical
Research Training and Medical
Education at the NIH Clinical Center on
Physician Careers in Academia and
Clinical Research (CC)
Summary: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on December 15,
2015, pages 77647–77648 and allowed
60-days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The NIH
Clinical Center (CC), National Institutes
of Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Direct Comments To OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
E:\FR\FM\25FEN1.SGM
25FEN1
Agencies
[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)]
[Notices]
[Page 9491]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03995]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: March 25, 2016.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Jay B. Sundstrom, Ph.D., Scientific Review
Official, Scientific Review Program, Division of Extramural
Activities, Room 3G11A, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5045,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 19, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-03995 Filed 2-24-16; 8:45 am]
BILLING CODE 4140-01-P